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PURPOSE. To examine how circulating immune mediators in vivo may affect gene and protein
expression at the RPE/choroid interface.
METHODS. Young mice were systemically infected with lymphocytic choriomeningitis virus
(LCMV) or continuously infused with IFN-c. RPE/choroid was isolated and analyzed with
whole-transcriptome gene expression microarrays. Selected gene expression findings were
validated at the protein level.
RESULTS. Both the systemic immune activation from virus infection and the sterile
systemically increased level of IFN-c resulted in increased expression of chemokine ligands,
chemokine receptors, and early complement components in isolates of RPE/choroid. These
findings were largely absent from LCMV-infected mice deficient in either the interferon a/b
receptor or IFN-c.
CONCLUSIONS. Together, these findings demonstrate that acute systemic immune activation
results in a local response at the RPE/choroid interface that may include chemokine-
dependent recruitment of inflammatory cells and engagement of the complement system.
This may represent a link between the systemic low-grade inflammation and the retinal
pathology observed in several multifactorial entities such as aging, AMD, and diabetes.
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Several entities affecting the retinal function such asdiabetes,1 AMD,2–4 and aging5 have all been associated with
systemic low-grade inflammation. Conversely, diseases charac-
terized by systemic inflammation have been associated with
ocular diseases. Acquired immunodeficiency syndrome and
myeloproliferative neoplasms have been associated with a
higher incidence of AMD,6,7 and diverse inflammatory diseases
including inflammatory bowel disease and arthritis have been
associated with an increased risk of posterior uveitis.8,9
However, the mechanism by which systemic inflammation is
connected to ocular disease has not been agreed on.
The immune status of the chorioretinal interface is to a large
extent governed by the RPE. Through the constitutive release
of immunomodulatory molecules, the RPE can suppress the
activation of T cells and promote the generation of regulatory T
cells.10,11 Upon various stimuli in vitro, the RPE induces and
increases the expression of cytokines,12 chemokines,13 and
early complement components.14 These stimuli include the
inflammatory mediators lipopolysaccharide (LPS), IL-1b, TNF-a,
and/or IFN-c. Less is known about possible immunomodulatory
functions of the choroid. However, recently we have demon-
strated that native choroidal melanocytes may harbor similar
functionality including secretion of chemokines and suppres-
sion of T cell activation.15
Systemically increased levels of IFN-c from systemic virus
infection in rodents has been shown to induce a transient
subretinal accumulation of retinal microglia,16 which indicates
that systemic inflammation contributes to the immune status of
the chorioretinal interface. The transcriptional response of the
choroidal/RPE interface to systemic inflammation has, however,
not been explored before.
Furthermore, while it has been demonstrated that aging
activates the RPE/choroid in rodents to upregulate the
expression of complement, chemokines and leukocyte adhe-
sion molecules,17–19 it has not been determined to what extend
this is due to age-related systemic low-grade inflammation or if
it reflects ocular aging processes such as accumulation of
lipofuscin or protein modifications from free-radical induced
oxidative processes.
The blood supply to the RPE and outer neuroretina derives
from the outer choroid, which is among the most highly
perfused tissues in the body.20 Therefore, we hypothesized that
RPE/choroidal-exposure to circulating immune mediators may
affect retinal immune homeostasis. To examine this, we
measured transcriptional changes in the RPE/choroid in
response to systemic viral infection and cytokine infusion,
and identified IFN-c as a central and sufficient mediator of RPE/
choroid immune activation.
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METHODS
Animals
WT C57BL/6 mice were obtained from Taconic Farms (Ry,
Denmark). Interferon-a/b receptor (IFNAR)/ and IFN-c/
C57BL/6 mice were the progeny of mice originally obtained
from The Jackson Laboratory (Bar Harbor, ME, USA). All mice
were housed under specific pathogen-free conditions and used
for experiments at the age of 8 to 12 weeks; all mice from
outside sources were allowed to acclimatize to the local
environment for at least 1 week before entering into
experiments. Unless stated otherwise, all experimental groups
contained four mice.
Induction and Measurement of Systemic Immune
Activation
Systemic immune activation was induced by infection with
lymphocytic choriomeningitis virus (LCMV) of the Armstrong
strain or mimicked by continuous infusion with recombinant
murine IFN-c (Peprotech, Rocky Hill, NJ, USA). For virus
infection, 104 plaque-forming units in 0.3 mL PBS were injected
into a tail vein. Intravenous inoculation of the low-invasive
Armstrong strain of LCMV is known to infect the lymphoid
organs, particularly the spleen, and elicit a potent antiviral CD8
T cell response with a substantial spill-over of proinflammatory
cytokines into the general circulation.21 IFN-c was delivered as
previously described.22 Briefly, 7-day osmotic pumps (Durect,
Cupertino, CA, USA) were filled with 50 lg IFN-c and placed in
a subcutaneous pocket in Avertin-anesthetized mice. Negative
controls included untreated mice and mice receiving PBS-filled
pumps. At the end of experiments, at time points indicated,
mice were bled into heparinized tubes, killed by cervical
dislocation, and ocular tissue and spleens were removed. To
verify immune activation, blood and spleens were analyzed.
Blood was centrifuged at 1000g for 15 minutes and the plasma
obtained was assayed for levels of IFN-a and IFN-c using bead-
based multiplex assay according to the manufacturer’s instruc-
tions (eBioscience, Bender Medsystems, Vienna, Austria).
Spleens were forced through a mesh, washed twice in RPMIþ
10% FCS, and 106 cells were transferred per well to a 96-well
plate in PFEA buffer (PBS with 2% FCS, 2 mM EDTA and 0.01%
azide). Cells were then stained in the dark for 30 minutes/48C
with a mixture of anti-mCD4-APC, anti-mCD8-APC-Cy7, anti-
mCD44-PE-Cy7, and anti-mCD62L-PE (all from Biolegend, San
Diego, CA, USA). After washing in PFEA buffer, acquisition of
data was performed on an LSR-II instrument (BD Biosciences,
Franklin Lakes, NJ, USA) and analyzed using commercial
software (FlowJo, version 7.6.5 for Windows; Tree Star, Inc.,
Ashland, OR, USA). Lymphocytes were gated from single cells
based on light scatter profiles in the forward and side scatter
detectors. Gates for CD4þ and CD8þ within the CD3þ T cell
subset were then analyzed for frequencies of effector memory
(CD44þ CD62L) subsets.
Harvest of Ocular Tissues
Ocular tissues were removed immediately following cervical
dislocation as previously described.19 Briefly, for the isolation of
RNA, eyes were hemidissected, the neuroretinas were removed
and the remaining RPE/choroid in the interior of the eyecups
was scraped off with a 25G needle and collected in RNA lysis
buffer containing reducing agent. RNA was isolated using spin
columns (Nucleospin RNA XS; Macherey-Nagel, Du¨ren, Ger-
many). RPE/choroid from right and left eyes were pooled; no
tissues from different mice were pooled. For the isolation of
protein, tissue fractions of RPE/choroid were homogenized in
PBS containing a protease inhibitor cocktail (Sigma-Aldrich
Corp., Copenhagen, Denmark) and 0.05% Triton X-100 as
previously described.23 Homogenates were centrifuged at
3000g for 30 minutes and the supernatants were stored at
808C until protein analysis.
Microarrays
At a microarray core-facility (Center for Genomic Medicine,
Copenhagen University Hospital, Copenhagen, Denmark), RNA
was processed for murine whole-transcriptome microarrays
(Mouse Gene 1.0 ST Array GeneChips; Affymetrix, Santa Clara,
CA, USA) according to the manufacturer’s protocol (Affymetrix
GeneChip; Affymetrix). Probe level data was processed using an
robust multichip average algorithm for adjustment of back-
ground and normalization (Expression Console 1.1; Affyme-
trix). Unannotated probe sets and probe sets with average
expression levels below the median in two groups were
removed from further analysis. Differentially expressed genes
were detected with a false discovery rate (FDR) < 0.001 and a
fold change >1.5 using the significance analysis of microarrays
(SAM version 4.0; Stanford University, Stanford, CA, USA).24
Gene expression values were normalized across samples using
the formula ([expression value]  mean[column]/SD[column])
and displayed as heatmaps generated in the multiple experi-
ment viewer (MeV version 4.8; Dana-Farber Cancer Institute,
Boston, MA, USA).25 Functional annotation of the differential
gene expression was carried out using a classification tool
(DAVID Bioinformatics Resources 6.7; National Institute of
Allergy and Infectious Diseases, NIH, david.abcc.ncifcrf.gov).26
Raw data CEL files have been deposited in the NCBI Gene
Expression Omnibus under accession number GSE73519.
Chemokine Protein Measurements in Tissue
Lysates and Plasma
Tissue homogenates and plasma samples were assayed for the
concentration of murine CCL2, CCL3, CCL5, and CXCL9 using
a multiplex cytometric bead-based assay (BD Biosciences).
Chemokine concentrations were normalized to protein con-
tent according to a standard bicinchoninic acid (BCA) protein
quantification assay.
Statistics
We used 1-way ANOVA with Dunnett’s Multiple Comparison Test
for analysis of cytokine and chemokine protein data and flow
cytometry data (GraphPad Prism version 4.03; GraphPad, La
Jolla, CA, USA). P values below or equal to 0.05 were considered
statistically significant. Statistical analysis of the microarray gene
expression data was carried out using the significance analysis of
microarrays as described in the microarray section.
Study Approval
Experiments were approved by the Danish Animal Experi-
ments Inspectorate and adhered to the ARVO Statement for the
Use of Animals in Ophthalmic and Vision Research.
RESULTS
Systemic LCMV Infection Results in T Cell
Activation and Increased Levels of Interferons in
the Circulation
As a model of systemic immune activation, mice were
systemically infected with LCMV. We evaluated the virus-
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induced T cell response days 3 and 8 postinfection (PI).
Because the plasma IFN-c level has previously been shown to
peak around day 6 during LCMV infection,27 we also measured
cytokines day 6 PI (Figs. 1A, 1B). At day 3 PI, increased levels of
plasma IFN-a and IFN-c were observed. While the IFN-a
returned to the basal level day 6 PI, IFN-c was further
increased. This corresponded to a marked CD8 T cell
activation, which included the expansion of primed CD8 T
cells; these cells have previously been demonstrated to have
the capacity to produce large amounts of IFN-c when triggered
by antigen.28 At day 8 PI, plasma IFN-c level returned to the
basal level.
Global Analysis of the RPE/Choroid
Transcriptional Response to Systemic Immune
Activation From LCMV Infection
To understand the molecular mechanisms in the posterior part
of the eye in response to the systemic inflammatory changes,
we isolated RPE/choroid days 3 and 8 PI and processed it for
whole-transcriptome microarrays. Gene expression levels were
compared with uninfected mice and identified as differentially
expressed based on a 1.5-fold change criterion and a false
discovery rate below 0.1%.
We observed a marked transcriptional response at both time
points. At day 3 PI 929 genes were downregulated and 474
genes were upregulated in RPE/choroid of infected mice. The
upregulated genes were subjected to functional annotation
using the gene ontology terms. Based on the number of genes
implicated, the top 10 list revealed functions relating to
inflammation and cell death (Figs. 2A, 2B). At day 8 PI, 176
genes were downregulated and 589 genes were upregulated
compared to baseline. As well as pathways associated with
inflammation, the functional annotation further included
pathways associated with cell activation and adhesion (Figs.
2C, 2D).
Abrogated Interferon Receptor Signaling Markedly
Reduces the LCMV Induced Gene Activation in the
Retina
Because the LCMV may bind and directly activate retinoic acid
inducible gene-1 (RIG-I) and toll-like receptors,29,30 of which
most are expressed by cultured RPE cells,31,32 we sought to
determine whether the observed transcriptional changes were
due to systemically increased levels of interferons or an off-
target effect of the virus. Therefore, we also tested the ocular
response to LCMV infection in mice with targeted deficiencies
in interferon signaling. The response to type I interferons,
which include IFNa, was tested in mice deficient in the
interferon a/b receptor (IFNAR/) on day 3 PI, whereas the
response to IFN-c was tested in mice deficient in IFN-c
(IFNc/) on day 8 PI. Of the genes upregulated in wild type
(WT) mice, a large fraction was not upregulated in the mutant
strains (Figs. 2A–D). This lack of response was most evident in
IFNc/ mice; only about 10% of the genes upregulated at day 8
FIGURE 1. Systemic immune activation by LCMV infection. (A) The splenic CD8 T cell compartment expanded day 8 PI. This included expansion of
effector/effector memory (CD44þ CD62L) CD4 and CD8 subsets. (B) The plasma concentrations of both IFN-a and IFN-c were increased at day 3.
At day 6 PI IFN-a returned to the basal level while the IFN-c level was increased further. At day 8 PI, plasma IFN-c level had also returned to the basal
level. (C) Plasma concentration of IFN-c in mice 5 days after implantation of IFN-c pumps corresponding to the time point for microarray analysis; 1-
way ANOVA with Dunnett’s multiple comparison test. **P < 0.01.
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FIGURE 2. Analysis of the RPE/choroid transcriptome from mice with LCMV infection or IFN-c infusion. (A, B) Global analysis of differential gene
expression in RPE/choroid day 3 PI, (C, D) day 8 PI and (E, F) after IFN-c infusion. The heatmaps display expression patterns of genes significantly
up- or downregulated compared to untreated mice according to significance analysis of microarrays using an FDR < 0.001 and a fold change >1.5.
Scale bar represents normalized expression values; yellow denotes upregulation, blue denotes downregulation. (B, D, F) The upregulated genes
were annotated according to Gene Ontology terms; shown are the top 10 pathways. (G) Venn diagram displaying the number of overlapping genes
upregulated in WT mice after infection with LCMV virus or infusion of IFN-c based on the transcriptome analysis.
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PI by LCMV in WT mice were upregulated in IFNc/ mice.
Notably, this pattern is different from the situation in organs
directly supporting viral replication, where absence of IFN-c
only moderately modifies the local inflammatory signature.33
Infusion of IFN-c Mimics the RPE/Choroid
Transcriptional Response to Systemic Immune
Activation From LCMV Infection
Because we knew from previous experience that even the
most sensitive analysis for presence of LCMV cannot exclude
minimal virus replication,34 we chose to employ another
approach to evaluate the role of circulating IFN-c versus local
infection. Thus, we analyzed the RPE/choroid response from
the exposure to systemic IFN-c in uninfected WT mice. In a
previous study, intraperitoneal bolus injections of IFN-c were
not associated with an altered retinal immune status,35
probably because of the short half-life of systemic IFN-c.36
Therefore, we infused IFN-c continuously via subcutaneously
placed osmotic pumps as previously described.22 At day 5,
after start of infusion, we euthanized the mice and isolated
ocular tissue and plasma for analysis. The plasma levels of IFN-c
in transfused mice averaged 2735 pg/mL (SD: 527) which is
comparable to peak levels observed in mice during infection
with LCMV22 or murine cytomegalovirus (MCMV).16 This was
significantly increased compared with untreated (mean: 63.8
pg/mL; SD: 23.3) and PBS-infused mice (mean: 44.8 pg/mL; SD:
54.4; Fig. 1D). Similar to LCMV infection, systemic IFN-c
exposure also had a marked effect on the RPE/choroid
transcriptome–inducing the upregulation of 574 genes. No
genes were differentially regulated in the PBS-infused mice,
thus confirming that the observed gene regulation in IFNc-
infused mice was not secondary to the surgical procedure or
any irritant effects from the pumps, but represented a response
specific to the IFN-c exposure (Fig. 2E). A great overlap was
observed in the top 10 gene ontology terms inferred from the
functional annotation of the upregulated genes compared with
the functional annotation of LCMV-infected mice (Fig. 2F).
Consistently, 76.0% of the IFN-c–induced genes were also
upregulated in RPE/choroid of LCMV-infected mice day 3 or 8
PI (Fig. 2G).
Systemic Immune Activation From LCMV Infection
Induces Upregulation of Chemokine Ligands in
RPE/Choroid Through Interferon Signaling
Systemic immune activation from LCMV infection–induced
RPE/choroid expression of several chemokine-encoding genes,
encoding chemoattractants known to be involved in recruit-
ment of inflammatory cells. Because of their probable
influence on the immune state of the chorioretinal interface,
we analyzed this family of chemoattractants separately (Fig. 3).
The transcripts Ccl2, Ccl3, Ccl5, Ccl6, Ccl7, Ccl8, Cxcl9,
Cxcl10, Cxcl11, Cxcl12, and Cxcl16 were all upregulated day 3
and/or day 8 PI. While few of these chemokines were
upregulated in the interferon mutant mice strains, the majority
were upregulated after IFN-c infusion. Additionally, of chemo-
kines not induced by LCMV infection, the IFN-c infusion also
induced the upregulation of Xcl1 and Ccl19 (Fig. 3C).
Together, this demonstrates that interferons are essential for
the LCMV-induced upregulation of chemokines in RPE/
choroid, and that systemically derived IFN-c is sufficient to
induce such upregulation in vivo.
Although previous results obtained from gene expression
microarrays have been shown to correlate strongly with RT-
PCR17,19 and protein13,14,17 findings of the RPE and RPE/
choroid, we proceeded to measure the protein levels of
selected chemokines in lysates of RPE/choroid from LCMV-
infected and IFNc-infused mice (Fig. 4A). Consistent with the
transcriptomics data, increased levels of CCL2 and CCL3 were
found in LCMV-infected mice. Corresponding to the relatively
high gene expression levels detected, increased levels of CCL5
and CXCL9 were found in both LCMV-infected and IFN-c–
infused mice. To examine if the increased local levels of
chemokines were simply spillover from the blood present in
the choroid tissue lysates, we also measured protein concen-
trations of these chemokines in blood plasma. We found
increased plasma levels of CCL5 and CXCL9 in LCMV-infected
mice and increased plasma level of CXCL9 in IFN-c–infused
mice (Fig. 4B). When related to total protein content, the level
of CCL3 was higher in RPE/choroid than in plasma in LCMV-
infected mice, and the level of CCL5 was higher in RPE/
choroid than in plasma in both LCMV-infected mice and IFN-c–
infused mice. Together, this indicates that the measured
protein reflects local synthesis, and therefore that the observed
gene upregulation translates to increased protein levels of
these analytes.
Differential Gene Expression Suggests RPE/
Choroid Recruitment of Leukocytes During
Systemic Immune Activation From LCMV Infection
The induced chemokine ligands are known to attract several
types of leukocytes including monocytic lineage cells (mono-
cytes, macrophages, microglia, and immature dendritic cells)
granulocytes (neutrophils, basophils, and eosinophils) and
lymphocytes (Type 1 and 2 helper, cytotoxic effectors,
memory T cells, B and NK cells).37,38 Consistent with this,
the transcripts Ccr2, Ccr5, Cxcr3, Cxcr6, and Cx3cr1 were
upregulated day 8 after infection (Fig. 5). These encode
chemokine receptors present on several types of leukocytes
including microglia/macrophages and antigen-primed T
cells,37,38 suggesting a chemokine-dependent recruitment of
T cells and microglia/macrophages to the RPE/choroid.
Consistent with this, the transcriptomic change day 8 PI
included both upregulation of several genes implicated in
cellular adhesion (Icam1, Vcam1, and Thy1) and the
interacting integrins (Itgb2 [encoding CD18], Itgal [CD11a],
Itgam [CD11b]). Further, several transcripts expressed by
microglia/macrophages (including Cd36, Cd45, Emr1 [F4/80]
and Cd86) and T cells (including Cd2, Cd3e, Cd3g, Cd8a,
Gzma, and Gzmb [encoding granzymes A and B]) were also
upregulated (data not shown).
Systemic Immune Activation From LCMV Infection
Induces Upregulation of Early Complement Genes
in RPE/Choroid Through Interferon Signaling
It has been suggested that the RPE/choroid contains a local
complement system with functional implications for retinal
immune homeostasis and pathology.39,40 Therefore, we ana-
lyzed the group of complement-encoding genes separately. We
found that all transcripts encoding the subunits necessary for
assembly of the C1 molecule and the classical C3 convertase
were upregulated after systemic infection with LCMV. The
concomitant upregulation of C3 and Cfb, encoding the
substrate for the classical C3 convertase and all subunits
necessary for the formation of the alternative C3 convertase,
may enable classical complement activation and amplification
of the C3 cleavage through the alternative amplification loop.
We also noted upregulation of C4, recently invoked as a T-cell
intrinsic regulator of inflammation in experimental autoim-
mune uveitis.41 Notably, of the complement-encoding genes
upregulated in WT mice in response to LCMV, only Cfb was
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FIGURE 3. Chemokine-ligand–encoding transcripts upregulated in the RPE/choroid after (A, B) LCMV infection or (C) IFN-c infusion. Shown are
mean expression values of genes significantly upregulated compared to untreated mice, according to significance analysis of microarrays using an
FDR < 0.001 and a fold change >1.5. Asterisks denote significance according to this method. Error bars represent standard deviation.
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upregulated in the interferon mutant mice strains, and all were
upregulated in WT mice following IFN-c infusion. This
demonstrates a marked dependence on the interferons in
upregulation of complement genes in the RPE/choroid
following systemic immune activation from LCMV infection
and that systemically derived IFN-c is sufficient to induce such
upregulation in vivo (Supplementary Fig. S1).
DISCUSSION
To characterize interactions between the RPE/choroid and the
immune system in vivo, we measured transcriptional changes
in RPE/choroid in response to systemic activation of the
immune system. Not only T cell activation from infection with
intravenous LCMV virus, but also the continuous infusion of
recombinant IFN-c resulted in upregulation of genes associated
with inflammation in the RPE/choroid.
The overlap of upregulated genes between the IFN-c–
infused uninfected mice and LCMV-infected WT mice demon-
strate that the induction of chemokine genes—to a large
extent—represents a specific response to the systemic
immune activation and cytokine release triggered by the
infection, and not just an off-target effect of the LCMV
infection. This conclusion is also supported by the fact that
there are distinct differences in the kinetics, but not identity, of
cytokine and chemokine genes expressed in the RPE/choroid,
compared with what has previously been described in virus-
infected organs such as the LCMV-infected central nervous
system.42 In directly virus-infected tissue, the IFN-induced
inflammatory profile is maintained and substantially augment-
ed following the recruitment of virus-specific effector T cells
and subsequent local antigen recognition.43 In the RPE/
choroid, this secondary augmentation was absent. Plasma
levels of IFN-a and IFN-c returned to basal levels at day 6 and 8
PI, respectively (Fig. 1B), and notably, the RPE/choroid gene
expression levels of these cytokines were low in unstimulated
mice and did not increase at day 3 or 8 PI (data not shown).
Thus, a high level of circulating IFN-c appears to be
intrinsically capable of inducing the upregulation of chemo-
kine genes in the RPE/choroid.
Inflammatory stimulation has previously been shown to
induce a range of chemokines in RPE cells. Of the chemokines
upregulated in RPE/choroid of virus-infected and IFN-c–infused
mice, CCL2, CCL5, CCL7, CCL8, CXCL9, CXCL10, and CXCL11
have been shown to be induced in human RPE in vitro by
FIGURE 4. Protein concentration of chemokines in (A) lysates of RPE/choroid and (B) plasma after LCMV infection or IFN-c infusion. Protein
concentrations were normalized to protein content as measured in the BCA assay. Asterisks denote significance compared with untreated mice; 1-
way ANOVA with Dunnett’s multiple comparison test. *P < 0.05; **P < 0.01.
FIGURE 5. Chemokine-receptor–encoding transcripts upregulated in the RPE/choroid after (A, B) LCMV infection or (C) IFN-c infusion. Shown are
mean expression values of genes significantly upregulated compared to untreated mice, according to significance analysis of microarrays using an
FDR < 0.001 and a fold change >1.5. Asterisks denote significance according to this method. Error bars represent standard deviation.
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soluble mediators from activated T cells or the combination of
TNF-a and IFN-c.13,44 In line with this, increased RPE/choroid
expression of Ccl2, Ccl5, Ccl8, Cxcl9, Cxcl10, and Cxcl16 have
been observed in aged mice17,45 and induction of Ccl2 has
been demonstrated in mouse RPE/choroid in response to laser-
induced choroidal neovascularization.46 In agreement with our
results, in vivo studies have also reported ocular accumulation
of leukocytes in response to the increased levels of chemo-
kines at the chorioretinal interface17,45–47 or in response to
neuroretinal IFN-c expression.48 Furthermore, a systemically
increased level of IFN-c was shown to induce the activation
and relocation of retinal CD45þ Iba1þ F4/80þ CD86þ microglia
to the subretinal space.16 Notably, in our system, transcripts for
all these macrophage/microglia markers were significantly
increased in the RPE/choroid by systemic LCMV infection as
well as IFN-c infusion. Finally, the findings of increased
transcripts of CXCL9 and CXCL1049 and CXCL10 protein50 in
RPE/choroid from patients with AMD and increased levels of
several chemokines including CCL2, CXCL9, and CXCL10 in
vitreous fluid from patients with neovascular AMD51 and
diabetic retinopathy52,53 corroborate the significance of
chemokines to retinal pathology.
The diversity of stimuli that induce the upregulation of
chemokine- and complement-encoding genes in RPE/choroid
suggests that this response represents a final common pathway
of the RPE/choroid. It is undetermined whether this response
is beneficial or detrimental. However, given that it can be
induced by stimuli such as systemic infection with a low-
virulence virus or short-term exposure to IFN-c, stimuli that
may be encountered multiple times during a lifetime, this
hardly represents a detrimental response on its own. Rather, it
may serve beneficial functions essential to tissue homeostasis
in the setting of acute systemic inflammation. Thus, the C1
molecule may serve to dampen inflammation locally through
binding to and facilitating the removal of apoptotic cells and
debris by macrophages or retinal microglia that are attracted by
the increased levels of chemokines.38,54,55 However, in a state
of chronic inflammation, the outcome may be detrimental.
Thus, mice chronically and systemically infected with murine
cytomegalovirus developed a more pathologic response to
laser-induced choroidal neovascularization.56 Also, the retinal
degeneration observed in aged mice of the A/J genetic
background has been explained by an augmented interferon
signaling already at a young age prior to development of the
pathologic changes of the retina.57 Together these observations
indicate that chronic, systemic inflammation may contribute to
the development of retinal pathology.
Strengths of this study include the in vivo approach for
measuring the RPE/choroid response to systemic immune
stimulation, and the use of whole transcriptome microarrays,
allowing unbiased examination of transcriptional responses.
Limitations include the short-term stimulation and lack of
functional assays. Thus, further studies are needed to
determine the functional effects of the RPE/choroid response
to acute immune activation and to determine whether such
effects are altered by the duration of stimulus, or other factors,
such as age. Further insights into this response system may
prove useful in designing therapeutic strategies aimed at
inhibiting or promoting the function of immune cells at the
RPE/choroidal interface.
In conclusion, with the purpose of characterizing the
interactions between the RPE/choroid and the immune system
in vivo, we analyzed the RPE/choroid transcriptional response
to acute systemic activation of the immune system. This
response included a marked upregulation of early complement
components and chemokine ligands and receptors. While
these findings were largely absent from mice deficient in IFN-c,
the continuous systemic infusion of IFN-c sufficed to induce
the upregulation of most of the chemokines induced by
systemic virus infection. Together, these findings indicate that
acute systemic immune activation, probably through increased
levels of proinflammatory mediators in the circulation, triggers
a local response at the RPE/choroid interface that may include
chemokine-dependent recruitment of inflammatory cells and
engagement of the complement system. If this also is the case
after systemic, chronic, low-grade inflammation, this may
represent a link between the observed systemic inflammatory
changes and the retinal pathology in several multifactorial
entities such as aging, AMD, and diabetes.
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